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Abstract
Background: Although early diagnosis and prompt treatment is important in preventing mortality from malaria,
presentation of symptomatic individuals is often relatively late. One possible contributing factor is that fear of covert
human immunodeficiency virus (HIV) testing delays presentation in adults. We aimed to survey the magnitude of such
concerns and their association with delayed presentation with suspected malaria.
Methods: The study design was a health facility-based cross-sectional survey. The study population consisted of adults
with suspected malaria who presented to health centres in central Ethiopia. Data were collected on attitudes to HIV
testing and the duration between onset of symptoms and treatment seeking for suspected malaria.
Results: Eight hundred and ten individuals provided data. Of these, 406 (50 %) perceived that HIV testing was
routinely done on blood donated for malaria diagnosis, and 327 (40 %) considered that community members
delayed seeking medical advice because of these concerns. Concerns about HIV testing were associated with
delays in attending for malaria diagnosis and treatment, with 117 individuals (29 %) of those with concerns
about covert HIV testing waiting for 4 days or more, compared to 89 (22 %) of those who did not have any
such concerns (p = 0.03). One hundred and twenty nine (16 %) individuals stated that concern about HIV
testing was the main reason for the delay in seeking treatment, and 46 % of these individuals presented after
experiencing symptoms of malaria infection for three days or more compared to 22 % of the 681 individuals
who had no such concerns (p < 0.001). Analysis stratified by health centre demonstrated that these associations were a
consequence of Meki health centre (odds ratio for duration of symptoms greater than 3 days if patient has concerns
about HIV testing was 8.72; 95 % confidence intervals 3.63 to 20.97).
Conclusions: In adults living in central Ethiopia, the perception that HIV testing accompanied the investigation of
suspected malaria was common. This is likely to impede presentation for early medical treatment in some areas and
represents a reversible risk factor that deserves further study.
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Background
Malaria is an important treatable cause of morbidity and
mortality, with 3.4 billion people globally estimated to
be at risk of infection in 2012, resulting in approximately
200 million cases of malarial infection and 600,000 deaths
annually [1]. In Ethiopia, malaria is one of the most import-
ant public health problems, representing the commonest
communicable disease [2] and imposing a high economic
cost on the country [3]. As malaria is treatable with prompt
medical care [4], the national malaria programme stresses
the importance of early treatment-seeking behaviour for
suspected infection [2].
Ethiopia is one of the countries in the sub-Saharan
Africa that have a generalized human immunodeficiency
virus (HIV) epidemic with about 750,000 people living
with HIV/AIDS [5]. The prevalence of HIV infection
among adults aged 15–49 years old in 2011 was esti-
mated to be 4.2 % in urban areas and 0.6 % in rural areas
[6]. Despite the availability of anti-retroviral treatment,
individuals may be reluctant to undergo testing of their
HIV status, as they do not wish to be exposed to the
knowledge and social consequences of a potential positive
diagnosis.
We recently reported data demonstrating that presen-
tation of children with suspected malaria was delayed
if their guardian were concerned that blood samples
collected for malaria diagnosis were being covertly tested
for HIV status without consent [7]. A similar hypothesis
was tested in adults, speculating that concerns about cov-
ert HIV testing were common and resulted in delay in the
presentation of symptomatic patients for investigation of
malaria. This hypothesis was tested using a cross-sectional
observational study design in Ethiopia in adults with
suspected malaria visiting health centres.
Methods
Study population
The study design was a health facility-based cross-
sectional survey. This study was conducted in East
Shewa Zone of Oromia Regional State in Ethiopia,
where malaria is one of the leading health problems.
Five health centres were included in the study and
data were collected in October and November 2012,
which represents the peak malaria transmission season in
this part of Ethiopia. Each health centre is led by medically
qualified clinicians, has diagnostic facilities for malaria
and covers a population of approximately 20,000 individ-
uals. All adults aged 16 years or over who presented with
symptoms consistent with malaria and gave finger-prick
blood for microscopic examination at the health centres
were eligible to participate in the study. All participants
gave informed consent and received standard treatment
for their presenting condition.
Sample size calculation
The aim was to recruit 850 individuals. The total sample
size allocated to each health centre was proportional to
the total patients tested for malaria in the previous
3 months (June-August, 2012) and individuals were re-
cruited consecutively until the estimated sample size was
achieved. Assuming that 20 % of patients had concerns
about HIV testing in population and 50 % have had
symptoms for 5 days or less, it was estimated that the
study would have over 90 % power (5 % risk of type I
error) to detect an absolute increase of 20 % in patients
who had concerns about HIV testing who experienced
malaria symptoms for 5 days or more compared to those
who had had no such concerns.
Data collection
A pre-tested structured questionnaire was initially de-
veloped in English and then back translated into local
language (Afan Oromo) and used for data collection.
The questionnaire collected data on socio-demographic
characteristics, concerns about HIV testing and duration
of symptoms. One data collector and one supervisor from
each health centre were trained to recruit the study partic-
ipants and implement the questionnaire. Subsequent diag-
nosis of malaria was done using blood film examination
under microscopy.
Statistical analysis
The main exposure of interest was the response to the
question ‘Are you concerned about HIV testing when you
visit a health facility for malaria diagnosis and treatment?’
All completed data were examined for completeness
and consistency. Initial analysis used Mann–Whitney
and Kruskal-Wallis tests to identify differences in the
duration of symptoms between different measures of
concerns about HIV testing and perceptions of these
concerns in the wider community. As the differences
observed were relatively small, with similar median
values as a consequence of the structure of the data,
the outcome variable of duration of time was categorized
into either less than or equal to three days and more than
three days. Statistical analysis used chi-squared testing
and subsequent analysis by logistic regression stratified by
health centre. The impact of urban and rural locations on
the primary exposure was explored as the prevalence of
HIV infection varied between these settings.
Ethical considerations
The study protocol was reviewed and approved by the
Research and Ethics Committee of the School of Public
Health at the College of Health Sciences. Informed con-
sent was obtained from each participant and confidenti-
ality was maintained. Lastly, information and education
was given to the study subjects with regard to malaria
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prevention, control, and early diagnosis and adequate
treatment, and about HIV counselling and testing.
Role of the funding source
The sponsors of the study had no role in study design,
data collection, data analysis, data interpretation, or
writing of the report. The corresponding author had full




A total of 810 adults provided data for analysis. The
demographics of the study participants are reported in
Table 1. Four hundred and fifty-seven individuals (56 %)
reported having symptoms of suspected malaria lasting
more than 2 days, and 75 (9 %) had sought health advice
prior to the current presentation (Table 2). The overall
prevalence of confirmed malaria was 25 % for participants
in the study.
Concerns about HIV testing
Four-hundred and six (50 %) individuals considered that
HIV testing was applied to blood given for malaria testing
at the health centre (Table 3); 233 (29 %) of individuals
considered that many or almost all members of the
community had similar beliefs that malaria testing
also involved HIV testing; 327 (40 %) of individuals con-
sidered that fear of HIV testing delayed presentation of
individuals with suspected malaria. Participants who sus-
pected that blood provided for malaria diagnosis was cov-
ertly tested for HIV had a median delay of three days
(interquartile range IQR 2 to 4) from the start of their
symptoms to clinical evaluation compared to a median of
three days (IQR 2 to 3) for those who did not hold this
belief (p < 0.01).
Concerns about HIV testing on blood donated for the
diagnosis of malaria were associated with delays in attend-
ing for treatment, with 117 individuals (57 %) of those
with concerns waiting for 4 days or more, compared to 89
(43 %) who did not have any such concerns (p = 0.03).
One hundred and twenty nine (16 %) individuals stated
that concern about HIV testing was the main reason for
the delay in seeking treatment, and 59 (46 %) of these
individuals presented after more than three days of symp-
toms compared to 147 (22 %) of individuals who did
not consider fear of HIV testing the cause for their
delay (p < 0.001). Table 4 demonstrates that delays in
seeking treatment varied between the five health centres
(p < 0.001, chi-squared test). The stratified analysis sug-
gested that much of the associations observed were driven
by data from Meki health centre with an odds ratio for
Table 1 Characteristics of participants
Characteristics Total Concern about covert HIV testing
(%) N = 810 Yes (%) N = 406 No (%) N = 404 p value*
Location
Urban 476 (59) 230 (57) 246 (61) 0.22
Rural 334 (41) 176 (43) 158 (39)
Sex
Male 397 (49) 189 (47) 208 (51) 0.16
Female 413 (51) 217 (53) 196 (49)
Age (years)
16–24 313 (39) 159 (39) 154 (38) 0.09
25–34 299 (37) 155 (38) 144 (36)
35–44 142 (18) 73 (18) 69 (17)
44+ 56 (7) 19 (5) 37 (9)
Highest level of education
Illiterate 209 (26) 119 (29) 90 (22) 0.15
Literate but no formal education 38 (5) 18 (4) 20 (5)
Primary school 276 (34) 133 (33) 143 (35)
Secondary school or higher 287 (35) 136 (33) 151 (37)
Electricity in household
Yes 529 (65) 255 (63) 274 (68) 0.13
No 281 (35) 151 (37) 130 (32)
*Chi-squared test
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duration of symptoms greater than 3 days if patient had
concerns about HIV testing of 8.72 (95 % confidence
interval 3.63 to 20.97).
Discussion
This is the first quantitative study to specifically assess
the prevalence of concerns about HIV testing and asso-
ciations with the time to presentation at health centres
of adults with suspected malaria living in Ethiopia. Our
analysis shows that half of the individuals with suspected
malaria were concerned that HIV testing was imple-
mented on all blood sampled for the diagnosis of mal-
aria, and that 40 % of our respondents considered that
these beliefs will result in relatively later presentation at
medical facilities for symptomatic patients. Collectively,
these concerns about covert HIV testing were associated
with delayed presentation for management of suspected
malaria, with these associations a consequence of data
from Meki health centre in particular.
The study has a number of strengths including the
prospective assessment of a priori hypothesis from a
population of adults with suspected malaria, who were
unaware of the hypothesis being tested, with a very high
response rate (minimising bias). The main limitation of
these data is the issue of generalisabilty to other cultural
settings. Although these observations are valid within
the communities in Central Ethiopia that we studied, it
is impossible to assume that these concerns regarding
HIV testing and delayed access to health care in general
are applicable elsewhere. In addition, our study popula-
tion could be biased by severity of disease, so that those
with more advanced disease are unable to attend the
health centres, and hence our observations are pertinent
only to those who attend health centres with symptoms
of malaria, although this is unlikely to account for the
association between delayed presentation and concerns
about HIV testing. Our data should thus be considered
to be hypothesis generating, and further regional studies
are required in a number of different settings to deter-
mine how prevalent the beliefs are that covert HIV test-
ing accompanies malaria blood testing in high HIV
prevalence countries.
A delay of over two days before obtaining medical as-
sessment after the initiation of symptoms of suspected
malaria occurred in 56 % of our study population, and
similar delays have been observed in Nigeria [8], Senegal
[9], Ethiopia [10, 11] and India [12, 13]. However, our
data were cross-sectional and demonstrating causality is
not possible using this study design. Future studies
should consider using representative prospective study
designs to study local differences in baseline attitudes to
HIV testing, and in particular their possible association
with late presentation of patients with malarial symp-
toms, adjusting for potential confounding factors such
as access to health facilities.
The current study was performed at the same time as
a second study that tested a related hypothesis in chil-
dren presenting with suspected malaria [7]. These data
demonstrated that 51 % of guardians of these children
perceived that HIV testing was done on blood donated
for malaria diagnosis, which is similar to the 50 % re-
ported in the current data. Children whose guardians
were concerned about covert HIV testing in cases of
suspected malaria presented later with a median delay of
three days compared to those children whose guardians
were not concerned about covert HIV testing who had a
median value of two days. While antiretroviral testing
and therapy is available in Ethiopia, the disease remains
a public health concern with stigma of having HIV infec-
tion being a particular problem despite the regular pro-
motion of health awareness campaigns to educate the
local population. The analysis stratified by health centre
demonstrated that the prevalence of concern about HIV
testing was common across all the regions studied, with
values ranging from 45 to 54 % of the populations stud-
ied, suggesting that this was not localised to just one
area. However, only in one health centre (Meki) did this
translate into a delay in presentation, and further investi-
gation is required to account for this. The fact that level
of education attained does not modify the concerns
Table 2 History of suspected malarial symptoms
Factors Total Location p value*
Urban Rural
Number of days of illness prior to
health centre attendance (%)
<1 78 (10) 53 (11) 25 (7) 0.02
1 62 (8) 38 (8) 24 (7)
2 213 (26) 139 (29) 74 (22)
3 251 (31) 140 (29) 111 (33)
4+ 206 (25) 106 (22) 100 (30)
Sought health advice prior to
visiting current health centre (%)
Yes 75 (9) 34 (7) 41 (12) 0.01
No 735 (91) 442 (93) 293 (88)
Took antimalarial tablets prior to
attendance at health centre (%)
Yes 65 (8) 23 (5) 42 (13) >0.001
No 136 (17) 79 (17) 57 (17)
No response 609 (75) 374 (79) 235 (70)
Positive laboratory test for
malaria (%)
Yes 204 (25) 108 (23) 96 (29) 0.05
No 606 (75) 368 (77) 238 (71)
IQR interquartile range
*Chi-squared test
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about covert HIV testing is an important negative finding,
that should inform future investigations in this area, as
these concerns are shared across all educational groups.
Our data can be compared with those from Gambella
Region of Ethiopia in 2008, where the prevalence of
refusal for HIV testing among women attending for ante-
natal care was 25 % [14], suggesting that there may be a
substantial minority of individuals in Ethiopia who do not
want to take advantage of HIV testing to know their sero-
logical status. To date, sparse data exist on how attitudes
to HIV impact on presentation with symptoms of malaria.
Individuals living in rural Cote d’Ivoire who were offered a
rapid diagnostic testing assay for malaria reported that
67 % had concerns that the blood would be used for HIV
Table 4 Odds ratio of impact of health beliefs of participants on duration of symptoms stratified by health centre
Health centre Total number
of individuals
Number of individuals with
symptoms ≥4 days (%)
Number of individuals concerned about
HIV testing when you visit a health facility
for malaria diagnosis and treatment (%)
Odds ratio of duration of symptoms
≥4 days if concerned about covert
HIV testing (95 % confidence intervals)
Abosto 139 53 (38) 65 (47) 0.49 (0.24 to 0.98)
Batu 180 36 (20) 94 (52) 1.02 (0.49 to 2.14)
Bulbula 147 17 (12) 79 (54) 1.26 (0.45 to 3.52)
Meki 175 48 (27) 92 (53) 8.72 (3.63 to 20.97)
Mojo 169 52 (31) 76 (45) 1.67 (0.87 to 3.24)
Table 3 Impact of health beliefs of participants on duration of symptoms
Factors Total (%) Median duration of
symptoms, days (IQR)*
Duration of symptoms P value*
≤3 days ≥4 days
Concerned about HIV testing when you visit a health facility for
malaria diagnosis and treatment
Yes 406 (50) 3 (2 to 4) 289 (48) 117 (57) 0.03
No 404 (50) 3 (2 to 3)
p < 0.01
315 (52) 89 (43)
How sure that covert HIV testing is done on malaria samples
Do not believe 404 (50) 3 (2 to 3) 316 (52) 88 (43) 0.01
Maybe 212 (26) 3 (2 to 3.5) 159 (26) 53 (26)
Very/completely sure 194 (24) 3 (2 to 4)
p = 0.003
129 (21) 65 (32)
Estimate of how many people in community believe that
malaria blood samples are also tested for HIV
None 269 (33) 2 (1 to 3) 219 (36) 50 (24) 0.004
Few 220 (27) 3 (2 to 3) 167 (28) 53 (26)
Many 188 (23) 3 (2 to 4) 126 (21) 62 (30)
Almost all/All 45 (6) 3 (2 to 4) 33 (5) 12 (6)
Do not know 88 (11) 3 (2 to 4)
p = 0.001
59 (10) 29 (14)
Consider that the fear of HIV testing is the reason for the delay
in people seeking an early diagnosis of malaria at health facility?
Yes 327 (40) 3 (2 to 4) 223 (37) 104 (50) <0.001
No 334 (41) 2 (2 to 3) 281 (47) 53 (26)
Do not know 149 (18) 3 (2 to 4)
p = 0.001
100 (17) 49 (24)
Concerns about HIV testing are main reason for delay in
presenting this time
Yes 129 (16) 3 (2 to 3) 70 (12) 59 (29) <0.001
No 681 (84) 3 (3 to 5)
p < 0.001
534 (88) 147 (71)
IQR interquartile range
*Non parametric test as appropriate (Mann–Whitney test, Kruskall-Wallis test)
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testing [15]. In Uganda, two separate qualitative studies
explored the feasibility of introducing rapid diagnostic
malaria assays. In the first qualitative study, the local
population again expressed concern that blood samples
collected for malaria could be used for HIV testing rather
than malaria [16]. In the second qualitative study, again
individuals were worried that ‘in most communities people
think that taking of blood means testing for HIV and some
do not want their HIV status disclosed’ [17].
Implications for policy
If concerns about HIV testing delay malaria diagnosis,
then this is obviously a concern for the local authorities
that provide public health services in these countries, as
malaria is a common disease that infects approximately
200 million individuals annually [1] and it is well recog-
nized that prompt treatment for those who present with
the infection is important to reduce morbidity and mor-
tality [18–20]. One option would be to evaluate further
targeted education for the public [21, 22], so that aware-
ness of the risk of delayed presentation with suspected
malaria by the erroneous concern that covert HIV testing
is administered to all blood tests is addressed directly.
One other possible explanation for our data from this and
our previous study in the same population [7] is that it is
actually true, that at times healthcare workers test blood
samples for HIV infection without fully informed consent
of the patient. Future studies may wish to clarify this issue
and that of the confidentiality of results in these commu-
nities, and could provide useful data to reassure the local
population that their blood is only used for the purposes
provided, which in itself may reduce some of the concerns
observed in our study population.
Conclusions
These data suggest that concerns about covert HIV test-
ing without informed consent are common in central
Ethiopia, and that these may result in delayed presentation
by adults with suspected malaria for medical treatment.
This provides a relatively novel risk factor that inhibits
prompt treatment of patients with malarial symptoms that
is potentially reversible, and provides the option of testing
non-medical interventions to improve earlier presentation
and hence treatment for this common infection.
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